Tempus AI, Inc.
Tempus AI operates an AI-powered precision medicine platform for data-driven clinical decision support in oncology and other disease areas, with a single congressional purchase signal ($50K-$100K) against zero lobbying, donations, federal contracts, or corporate insider buys.
BusinessWhat TEM does
Tempus AI provides an artificial intelligence-enabled precision medicine platform that aggregates and analyzes clinical, molecular, and imaging data to support therapeutic decision-making, primarily for oncologists, with revenue likely derived from diagnostic testing, data analytics services, and software subscriptions to healthcare providers and biopharma companies.
Lifetime Government AwardsTEM federal contracts
TEM doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Politicians Trading TEMMembers of Congress with recent TEM positions
Congressional TradesWho in Congress is trading TEM
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting TEMLive legislation impacting this stock
Political ProfileWhere TEM sits in Washington
[object Object]
STRUCTURAL: High regulatory density (8 healthcare bills, impact_ratio 0.0005 each) but zero lobbying spend (get_political_influence.lobbying.total_income: 0), zero donations, zero federal contracts. EVIDENTIARY: Single congressional purchase ($50K-$100K, bioguide_id P000197) against zero corporate insider buys (get_corporate_insider_signal.total_buys: 0, tier F). Net: Isolated trade signal lacks corroborating structural support.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
High regulatory density from healthcare legislation impacting revenueCongress (multiple bills)"Recent bill_impacts array shows 8 healthcare bills with impact_ratios of 0.0005 each, indicating multiple legislative touchpoints."
-
Potential FDA regulation of AI/software as a medical deviceFDA"Sector is healthcare with AI component; no explicit carveouts in bill_carveouts array, implying general regulatory exposure."
Regulatory opportunities
-
Potential for federal contracts in health data analyticsHHS, VA"get_government_precedent.federal_contracts_summary is null, indicating no current footprint but sector alignment."
Capitol Hill AlliesChampions & critics
Congressional champions
- Unknown Unknown
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for TEM — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades TEM
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord